Market Place
Sourcing Support
All News #Library
Biotech
Creative Medical Posts 93% Response in Knee OA Program
28 Apr 2026 //
GLOBENEWSWIRE
Creative Medical Holdings Achieves Second WHO INN Milestone
10 Feb 2026 //
GLOBENEWSWIRE
Creative Medical Reports Positive Interim ADAPT Trial Data
13 Jan 2026 //
GLOBENEWSWIRE
Creative Medical Technology Holdings Gets FDA Approval
06 Jan 2026 //
GLOBENEWSWIRE
Creative Medical Completes ADAPT Trial for CELZ-201-Olastrocel
17 Dec 2025 //
GLOBENEWSWIRE
Creative Medical Secures WHO Approval for Olastrocel
02 Dec 2025 //
GLOBENEWSWIRE
Creative Medical Launches Regenerative BioDefense for Veterans
30 Oct 2025 //
GLOBENEWSWIRE
Creative Medical Technology Holdings Secures $4.2M In Proceed
29 Oct 2025 //
GLOBENEWSWIRE
Creative Medical Technology Holdings Issues Shareholder Letter
27 Oct 2025 //
GLOBENEWSWIRE
Creative Medical Technology Congratulates 2025 Nobel Laureates
07 Oct 2025 //
GLOBENEWSWIRE
Creative Medical Gets FDA Fast Track for CELZ-201-DDT Therapy
13 Aug 2025 //
GLOBENEWSWIRE
Creative Medical Gets ImmCelz™ Nod for Heart Failure Therapy
11 Jul 2025 //
GLOBENEWSWIRE
Creative Medical gets FDA clearance for Chronic Lower Back Pain
20 Mar 2025 //
GLOBENEWSWIRE
Creative Medical Raises $3.7M Via Warrant Exercise Agreements
06 Mar 2025 //
GLOBENEWSWIRE
Creative Medical Applauds IVF Expansion, Highlights OvaStem Growth
20 Feb 2025 //
GLOBENEWSWIRE
Creative Medical’s StemSpine Data Shows Reduced Opioid Use In CLBP
14 Feb 2025 //
GLOBENEWSWIRE
Creative Medical Shows 1-Year Positive Data In AlloStem T2D
11 Feb 2025 //
GLOBENEWSWIRE
Creative Med Tech Expand Collaboration with Greenstone Biosciences
05 Feb 2025 //
GLOBENEWSWIRE
Creative Medical Reports Positive Phase 1/2 for Chronic Back Pain
30 Jan 2025 //
GLOBENEWSWIRE
Creative Med Tech Advances FDA Cleared ADAPT Trial for Back Pain
13 Nov 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.